Changing – Page 3

IGM Biosciences Undergoes Strategic Pivot to Autoimmune Diseases, Overhauls Leadership and Reduces Workforce

7 months ago talkbio0Tagged Autoimmune Diseases, Biosciences, Changing, Immunoglobulin M, imvotamab, Leadership, strategic pivot, T cell-engaging IgM antibodies

IGM Biosciences, autoimmune diseases, strategic pivot, T cell-engaging IgM antibodies, leadership changes, workforce reduction, imvotamab, IGM-2644

Navigating Challenges and Opportunities in the 2024 Life Sciences Industry Outlook

8 months ago talkbio0Tagged Artificial Intelligence, Attitude, Biotechnology, Changing, drug price, Life Sciences Industry, regulatory, shortage, Supply Chain Security, Talent

Life Sciences Industry, 2024 Outlook, Biotechnology, Medical Devices, Artificial Intelligence, Drug Pricing, Regulatory Changes, Supply Chain Security, Talent Shortage

Aeterna Zentaris Rebrands as COSCIENS Biopharma: A New Era in Biopharmaceuticals

9 months ago talkbio0Tagged Adult, Aeterna Zentaris, Biological Factors, Biopharma, Changing, COSCIENS, development aspects, Diagnostic tests, Macrilen, rebranding, Somatotropin deficiency

Aeterna Zentaris, COSCIENS Biopharma, biopharmaceuticals, rebranding, name change, therapeutic development, diagnostic tests, Macrilen, adult growth hormone deficiency

UCB’s Strategic Shift: Bristol Myers ADC Partner’s CEO Takes the Helm

12 months ago talkbio0Tagged Administration occupational activities, CEO, Changing, Drug Industry, Myers, Partner in relationship, strategic shift, therapeutic autologous dendritic cells, UCB

UCB, management changes, CEO, Bristol Myers, ADC partner, strategic shift, pharmaceutical industry.